Effect of Mutation on an Aggregation-Prone Segment of p53: From Monomer to Dimer to Multimer

Atanu Das1, Dmitrii E Makarov1,2

  • 1Department of Chemistry, University of Texas at Austin , Austin, Texas 78712, United States.

Insights

Tumor suppressor p53 aggregation accelerates cancer. Atomistic simulations reveal a specific p53 fragment

Area of Science:

  • Biophysics
  • Molecular Biology
  • Cancer Research

Background:

  • Protein aggregation and amyloid formation are linked to various diseases.
  • Amyloid formation of tumor suppressor p53 can impair its function, potentially accelerating cancer progression.
  • Understanding p53 aggregation mechanisms is crucial for designing effective cancer therapeutics.

Purpose of the Study:

  • To characterize the aggregation process of an aggregation-prone p53 fragment (residues 252-258).
  • To evaluate the efficacy of the I254R mutant in suppressing p53 aggregation.
  • To elucidate the structural and mechanical changes induced by the I254R mutation.

Main Methods:

  • Atomistic simulations were employed to study p53 fragment aggregation.
  • The study analyzed the structural stability and mechanical dissociation of wild-type and mutant p53 fragments.
  • Aggregation propensity and self-assembly characteristics were investigated.

Main Results:

  • The wild-type p53 fragment forms stable, parallel β-sheet rich dimers that dissociate sequentially under force.
  • The wild-type fragment exhibits high aggregation propensity, forming parallel peptide structures.
  • The I254R mutation destabilizes the dimer, alters dissociation to cooperative unfolding, reduces aggregation propensity, and changes peptide orientation in aggregates.
  • Adding the wild-type sequence partially restores the aggregation propensity of the I254R mutant.

Conclusions:

  • The I254R mutation significantly impacts p53 fragment aggregation, reducing its propensity and altering its structural dynamics.
  • These findings provide insights into the molecular mechanisms of p53 aggregation and potential therapeutic strategies.
  • Further research can explore the modulation of p53 aggregation for cancer treatment.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
9.9K
Cooperative Allosteric Transitions01:58

Cooperative Allosteric Transitions

Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
9.3K
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
12.5K
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
6.9K
Mismatch Repair01:36

Mismatch Repair

Overview
44.5K